Clinical Trial Update: Ph. II Temozolomide + O6-BG in Treatment of Pts w Temozolomide-Resistant Malignant Glioma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating temozolomide with O6-benzylguanine in temozolomide-resistant malignant glioma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaplastic Glioma
• Glioblastoma Multiforme

Drugs mentioned

• O6-Benzylguanine (O6-Benzylguanine)
• Temodar (Temozolomide)

Snippet

Sponsor: Duke University | Conditions: Glioblastoma Multiforme, Anaplastic Glioma | Phase 2 | Status: COMPLETED